Federal Register / Vol. 66, No. 126 / Friday, June 29, 2001 / Notices 34697

Place: National Cancer, Institute, Building

31, C Wing, 6th Floor, Conference Rooms 6,

9000 Rockville Pike, Bethesda, MD 20892.

Contact Person: Abby B. Sandler, Scientific

Review Administrator, Institute Review

Office, Office of the Director, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard, room 7031, Rockville,

MD 20852, (301) 496–7628.

Any interested person may file written

comments with the committee by forwarding

the statement to the Contact Person listed on

this notice. The statement should include the

name, address, telephone number and when

applicable, the business or professional

affiliation of the interested person.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: June 20, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–16343 Filed 6–28–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, P01

Program Project Application.

Date: July 19, 2001.

Time: 1 p.m. to 6 p.m.

Agenda: To review and evaluate grant

applications.

Place: National Cancer Institute, 6116

Executive Blvd., Room 8139, Rockville, MD

20852, (Telephone Conference Call).

Contact Person: Shakeel Ahmad, PhD,

Scientific Review Administrator, Grants

Review Branch, National Cancer Institute,

National Institutes of Health, 8th floor, room

8139, 6116 Executive Boulevard, Bethesda,

MD 20892, 301–594–0114.

Any interested person may file written

comments with the committee by forwarding

the statement to the Contact Person listed on

this notice. The statement should include the

name, address, telephone number and when

applicable, the business or professional

affiliation of the interested person.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: June 20, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–16344 Filed 6–28–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, Review of

a Program Project Grant Application.

Date: July 18–20, 2001.

Time: 7:30 p.m. to 12 p.m.

Agenda: To review and evaluate grant

applications.

Place: Sheraton Palo Alto, 625 El Camino

Real, Palo Alto, CA 94301.

Contact Person: William D. Merritt, PhD.,

Scientific Review Administrator, Grants

Review Branch, National Cancer Institute,

National Institutes of Health, 6116 Executive

Boulevard, Room 8034, MSC 8328, Bethesda,

MD 20892–8328, 301–496–9767.

Any interested person may file written

comments with the committee by forwarding

the statement to the Contact Person listed on

this notice. The statement should include the

name, address, telephone number and when

applicable, the business or professional

affiliation of the interested person.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: June 21, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–16348 Filed 6–28–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel,

Fundamental Technologies for the

Development of Biomolecular Sensors.

Date: July 24–25, 2001.

Time: 8 am to 6 pm.

Agenda: To review and evaluate contract

proposals.

Place: Ramada Inn, 1775 Rockville Pike,

Rockville, MD 20852.

Contact Person: Sherwood Githens,

Scientific Review Administrator, National

Institutes of Health, National Cancer

Institute, Special Review, Referral and

Resources Branch, 6116 Executive Boulevard,

Room 8068. Bethesda, MD 20892, (301) 435–

1822.

Name of Committee: National Cancer

Institute Special Emphasis Panel,

Fundamental Technologies for the

Development of Biomolecular Sensors.

Date: July 26–27, 2001.

Time: 8 am to 6 pm.